These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Prevention of Rhesus sensitization using anti-D, ten years after initiation of the first studies]. Schneider J Z Geburtshilfe Perinatol; 1972 Feb; 176(1):2-16. PubMed ID: 4553933 [No Abstract] [Full Text] [Related]
25. [Immunological aspects of the prevention of hemolytic disease of the newborn]. Antonian AK Zh Eksp Klin Med; 1973; 13(6):44-9. PubMed ID: 4215267 [No Abstract] [Full Text] [Related]
27. [Experience with the use of native anti-rhesus immunoglobulin for prevention of hemolytic disease of the newborn]. Timoshenko LV; Khilobok VI; Gamachek IK; Gorobets EI; Komarova SI Pediatr Akus Ginekol; 1978; (4):41-2. PubMed ID: 693104 [No Abstract] [Full Text] [Related]
28. [Preventive care and prenatal therapy of hemolytic disease of newborn]. Stamm H Ther Ggw; 1971 Nov; 110(11):1657-8 passim. PubMed ID: 5003495 [No Abstract] [Full Text] [Related]
29. Prophylaxis and treatment of viral hepatitis. Damjanovic V; Brumfitt W J Antimicrob Chemother; 1980 Jan; 6(1):11-32. PubMed ID: 6766920 [No Abstract] [Full Text] [Related]
30. Current problems in prophylactic treatment of Rh-erythroblastosis. J Reprod Med; 1971 May; 6(5):232-55. PubMed ID: 4937675 [No Abstract] [Full Text] [Related]
31. [Activity of the Center for study of Rh factors of the Clinica Ostetrica e Ginecologica of the University of Naples in the prevention of hemolytic disease of the newborn]. Paladini A; Di Martino D; De Luca P; Rascio B; Di Lieto A Arch Ostet Ginecol; 1969 Dec; 74(6):461-75. PubMed ID: 5406384 [No Abstract] [Full Text] [Related]
32. [Administration of anti-D-gamma globulin in the prevention of hemolytic disease of the newborn]. Mrázová M; Valnícek S; Vacl J Cesk Gynekol; 1972 May; 37(4):236-7. PubMed ID: 5027209 [No Abstract] [Full Text] [Related]
33. Rh hemolytic disease of the newborn: its cause and prevention. Pollack W Prog Clin Biol Res; 1981; 70():185-302. PubMed ID: 6273932 [No Abstract] [Full Text] [Related]
34. Communicable diseases and immunizations. Cranston L Can Nurse; 1976 Jan; 72(1):34-40. PubMed ID: 1253141 [No Abstract] [Full Text] [Related]
35. Epidemiology of Rh hemolytic disease of the newborn, United States, 1960-1979. Adams MM; Gustafson J Prog Clin Biol Res; 1981; 70():213-7. PubMed ID: 6273934 [No Abstract] [Full Text] [Related]
36. [Gamma globulin in the prevention of infectious diseases in an infantile comunity]. Pizzi R Minerva Pediatr; 1968 Nov; 20(46):2382-9. PubMed ID: 4178120 [No Abstract] [Full Text] [Related]
37. [Comparative analysis of the effects to date of the prevention of Rh incompatibility]. Jedwabny A; Suchocki S; Bobrowska G Acta Haematol Pol; 1988; 19(1-2):56-8. PubMed ID: 2853507 [No Abstract] [Full Text] [Related]
38. [Current status of the prevention of alloimmunization]. Pinon F Soins Gynecol Obstet Pueric Pediatr; 1983; (27-28):33-4. PubMed ID: 6558879 [No Abstract] [Full Text] [Related]
39. The management of large Rh o (D) incompatible feto-maternal bleedings with anti-Rh o (D) immunoglobulins. Vermylen C Ann Ostet Ginecol Med Perinat; 1970 Jul; 92(7):451. PubMed ID: 5526985 [No Abstract] [Full Text] [Related]
40. Pregnancy outcome following infections by coxsackie, echo, measles, mumps, hepatitis, polio and encephalitis viruses. Ornoy A; Tenenbaum A Reprod Toxicol; 2006 May; 21(4):446-57. PubMed ID: 16480851 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]